Meeter Dalen
Singular Genomics Systems, Inc. · Chief Financial Officer
Meeter Dalen is listed in public filings as officer: Chief Financial Officer. This Meeter Dalen insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Singular Genomics Systems, Inc. (OMIC). Investors use Meeter Dalen's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $06.2k shares | OtherFeb 21, 2025 | $1.4M6.2k shares | $225.00 | -- | |
| $0833 shares | OtherFeb 21, 2025 | $549.8K833 shares | $660.00 | -- | |
| $01.7k shares | OtherFeb 21, 2025 | $447.3K1.7k shares | $268.50 | -- | |
| $06.7k shares | OtherFeb 21, 2025 | $256.0K6.7k shares | $38.40 | -- | |
| --1.9k shares | OtherFeb 21, 2025 | Disclosure amount unavailable1.9k shares | -- | -- | |
| $09.5k shares | OtherFeb 21, 2025 | $190.0K9.5k shares | $20.00 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --6k shares | Grant / ExerciseFeb 9, 2025 | Disclosure amount unavailable500 shares | -- | -- | |
| --1.9k shares | Grant / ExerciseDec 15, 2024 | Disclosure amount unavailable209 shares | -- | -- | |
| --6.5k shares | Grant / ExerciseNov 9, 2024 | Disclosure amount unavailable500 shares | -- | -- | |
| --2.1k shares | Grant / ExerciseSep 15, 2024 | Disclosure amount unavailable209 shares | -- | -- | |
| --7k shares | Grant / ExerciseAug 9, 2024 | Disclosure amount unavailable500 shares | -- | -- | |
| --68.8k shares | Grant / ExerciseJun 15, 2024 | Disclosure amount unavailable6.3k shares | -- | -- |